BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
8 results:

  • 1. An unusual approach for a cervical mass: sternotomy for the treatment of a giant cervico-thoracic lipoma.
    Petruzzi G; Trozzi L; Moretto S; De Virgilio A; Melis E; Gallina FT; Pichi B; Campo F; Facciolo F; Pellini R
    Acta Biomed; 2022 Jan; 92(6):e2021477. PubMed ID: 35075061
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the mdm2-P53 pathway.
    Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
    Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
    Jung H; Bae GE; Kim HM; Kim HS
    Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
    Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
    Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
    DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. No association between SNP309 promoter polymorphism in the mdm2 and cervical cancer in a study from northeastern Brazil.
    Meissner Rde V; Barbosa RN; Fernandes JV; Galvão TM; Galvão AF; Oliveira GH
    Cancer Detect Prev; 2007; 31(5):371-4. PubMed ID: 18023538
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aberrant cell cycle regulation in cervical carcinoma.
    Kim YT; Zhao M
    Yonsei Med J; 2005 Oct; 46(5):597-613. PubMed ID: 16259056
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of tumour suppressors and viral oncoproteins in cervical carcinogenesis.
    Anton M; Horký M; Bláha O
    Ceska Gynekol; 2000 Jul; 65(4):275-8. PubMed ID: 11039236
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.